Skip to main content
. 2021 Sep 16;11:716436. doi: 10.3389/fcimb.2021.716436

Table 1.

Protocols tested for assessing inactivation using lysis buffers.

Manufacturer, RNA extraction kit, platform Reagents (volume/sample) Active virucidal components* Reagent:sample ratio
Qiagen, ACL buffer (190 µl) GITC 30% to <50% 1.6:1
QIAamp 96 Virus QIAcube HT Kit
(Cat #: 57731), ATL buffer (100 µl) 1% to <3% SDS
Qiagen QIAcube HT.
(Referred to here as Qiagen protocol) Proteinase K (20 µl)
Carrier RNA (5 µl)
MS2 (10 µl)
Thermo Fisher, Lysis binding buffer (350 µl) GITC 55%–80% <0.001% acrylamide 3.8:1
MagMAX Pathogen RNA/DNA kit Zwittergent
(Cat #: 4462359),
KingFisher Flex.
(Referred to here as MagMAX Protocol 1) Isopropanol (300 µl) 100% 2-propanol
Carrier RNA (2 µl)
Water (100 µl)
MS2 (10 µl)
Thermo Fisher, Lysis binding buffer (265 µl) GITC 55%–80% <0.001% acrylamide 1.4:1
MagMAX viral/pathogen nucleic acid isolation kit Zwittergent
(Cat #: A48310),
KingFisher Flex.
(Referred to here as MagMAX Protocol 2) Proteinase K (5 µl)
Water (magnetic beads) (10 µl)
MS2 (10 µl)

*As identified directly from components or manufacturer information or inferred from the associated MSDS.

Water was used to replace the magnetic beads, as the washing steps described below would not remove the beads, and the beads interfered with the read-out of the TCID50 assay.

GITC, Guanidinium thiocyanate; SDS, Sodium dodecyl sulphate.